Comparing the soluble urokinase-type plasminogen activator receptor (suPAR) levels between individuals with subjective cognitive decline and mild cognitive impairment

被引：0
|
作者：
Batun, G. Cetiner [1 ]
Gultekin, G. [1 ]
Yuruyen, M. [2 ]
Yavuzer, H. [3 ]
Armutcu, F. [4 ]
Emul, M. [1 ]
Kocabasoglu, N. [1 ]
机构：
[1] Istanbul Univ, Med Sch Cerrahpasa, Psychiat, Istanbul, Turkey
[2] Istanbul Univ, Med Sch Cerrahpasa, Dept Geriatr, Istanbul, Turkey
[3] Istanbul Univ, Med Sch Cerrahpasa, Geriatr, Istanbul, Turkey
[4] Istanbul Univ, Med Sch Cerrahpasa, Biochem, Istanbul, Turkey
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2016年 / 26卷
关键词：
CANCER;
D O I：
10.1016/S0924-977X(16)31734-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.5.a.004
引用
收藏
页码：S637 / S638
页数：2
相关论文
共 50 条
  • [21] Evaluation of soluble urokinase-type plasminogen activator receptor (suPAR) quick test for triage in the emergency department
    Kumar, Pratyush
    Kakar, Atul
    Gogia, Atul
    Waziri, NIamatullah
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2019, 8 (12) : 3871 - 3875
  • [22] Hyperglycemia is associated with lower levels of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in wound fluid
    Akinci, Bans
    Terzi, Cem
    Sevindik, Gokmen
    Yuksel, Faize
    Tunc, Ulku Aybuke
    Tunali, Sunay
    Yesil, Sena
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2014, 28 (06) : 844 - 849
  • [23] The Relationship Between Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels and Treatment Response in Patients With Glomerulonephritis: A Single-Center Experience
    Issever, Kubilay
    Dheir, Hamad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [24] Circulating Levels of Urokinase-Type Plasminogen Activator (uPA) and its Soluble Receptor (suPAR) in Patients with Atopic Eczema/Dermatitis Syndrome
    Alicja Kasperska-Zajac
    Barbara Rogala
    Inflammation, 2005, 29 : 90 - 93
  • [25] Circulating levels of urokinase-type plasminogen activator (uPA) and its soluble receptor (suPAR) in patients with atopic eczema/dermatitis syndrome
    Kasperska-Zajac, Alicja
    Rogala, Barbara
    INFLAMMATION, 2005, 29 (2-3) : 90 - 93
  • [26] Sex Differences in Circulating Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels and Adverse Outcomes in Coronary Artery Disease
    Mehta, Anurag
    Desai, Shivang R.
    Ko, Yi-An
    Liu, Chang
    Dhindsa, Devinder S.
    Nayak, Aditi
    Hooda, Ananya
    Martini, Mohamed A.
    Ejaz, Kiran
    Sperling, Laurence S.
    Reiser, Jochen
    Hayek, Salim S.
    Quyyumi, Arshed A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (05):
  • [27] Soluble urokinase plasminogen activator receptor (suPAR) levels in healthy pregnancy and preeclampsia
    Toldi, Gergely
    Biro, Edina
    Szalay, Balazs
    Stenczer, Balazs
    Molvarec, Attila
    Rigo, Janos, Jr.
    Vasarhelyi, Barna
    Beko, Gabriella
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (11) : 1873 - 1876
  • [28] Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in ankylosing spondylitis
    Toldi, Gergely
    Szalay, Balazs
    Beko, Gabriella
    Kovacs, Laszlo
    Vasarhelyi, Barna
    Balog, Attila
    JOINT BONE SPINE, 2013, 80 (01) : 96 - 98
  • [29] RELEVANCE OF THE SOLUBLE UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) IN A RECIPIENT AND LIVING DONOR KIDNEY TRANSPLANT COHORT
    Jehn, U.
    Schuette-Nuetgen, K.
    Pavenstaedt, H.
    Suwelack, B.
    Reuter, S.
    TRANSPLANT INTERNATIONAL, 2020, 33 : 15 - 15
  • [30] Soluble urokinase-type plasminogen activator receptor (suPAR) is a risk indicator for eGFR loss in kidney transplant recipients
    Ulrich Jehn
    Katharina Schütte-Nütgen
    Ute Henke
    Hermann Pavenstädt
    Barbara Suwelack
    Stefan Reuter
    Scientific Reports, 11
12345